cagrisema glp 1 vs Tirzepatide: 23% Weight Loss in Phase 3 Trial Novo Nordisk has officially filed

Bariatric surgery or GLP-1 medication may help patients lose weight

Each ingredient in the formulation was meticulously-chosen for its bioavailability, effectiveness and clinical substantiation

Feel balanced, energized, and confident every step of the way

Ro, the leading direct-to-patient healthcare company, today announced that it is working with Eli Lilly to launch the recently FDA-approved Zepbound (tirzepatide) KwikPen nationwide on its platform

Development of a ligand-based proximity labeling strategy enables interrogation of the native cell membrane interactome for the GLP-1 receptor in two cell types, revealing new regulators of receptor-mediated signaling and cell responses.

Additionally, these routine blood tests can help your prescriber (and you!) determine the effectiveness of the medication, offering valuable insights into whether dosing adjustments or supplementary treatments are required